Protalix BioTherapeutics Inc. (PLX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Protalix BioTherapeutics ...

    AMEX: PLX · Real-Time Price · USD
    1.60
    0.06 (3.90%)
    At close: Sep 08, 2025, 3:59 PM
    1.56
    -2.50%
    Pre-market: Sep 09, 2025, 05:10 AM EDT

    Protalix BioTherapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 2.93M 8.31M -14.93M -27.58M
    Depreciation & Amortization
    		 1.3M 1.19M 1.09M 1.12M
    Stock-Based Compensation
    		 3.25M 3.45M 2.08M 2.38M
    Other Working Capital
    		 -4K -13.16M -7.17M 13.23M
    Other Non-Cash Items
    		 138K -638K -1.23M 3.09M
    Deferred Income Tax
    		 236K -3.09M n/a 813K
    Change in Working Capital
    		 811K -10.54M -12.02M 9.9M
    Operating Cash Flow
    		 8.67M -1.32M -25M -10.29M
    Capital Expenditures
    		 -1.28M -1.15M -628K -1.46M
    Cash Acquisitions
    		 n/a n/a n/a 53K
    Purchase of Investments
    		 -15M -20.42M -16M -37.84M
    Sales Maturities Of Investments
    		 20.42M 5M 11M 57.84M
    Other Investing Acitivies
    		 83K -142K 593K 327K
    Investing Cash Flow
    		 4.22M -16.71M -5.04M 18.92M
    Debt Repayment
    		 -20.42M n/a n/a -34.12M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 712K 2K 46.2M
    Financial Cash Flow
    		 -16.79M 24.67M 8.24M 12.08M
    Net Cash Flow
    		 -3.87M 6.52M -21.87M 20.72M
    Free Cash Flow
    		 7.39M -2.47M -25.63M -11.74M

    Add to Watchlist